Shilpa Medicare Shares Skyrocketed 11% Successful Phase 3 Clinical Trial
The shares of Shilpa Medicare Ltd skyrocketed 11% on 26 August following the company’s announcement of a positive result in Phase 3 trials for SMLNUD07,...
Use UNICORN Signals App
By EquityPandit
